source
- Why Axiom hopes it’s ‘solved 2 major potholes’ that have hurt other stem cell biotechsWhen Axiom's stem cell therapy demonstrated a 0% mortality rate over two years in potentially fatal newborn neurological diseases this week, the biotech's leadership saw a broader validation for th…Fierce Biotech · 15d ago↗ source
- Diamantas backtracks on Makary’s policies issued in journal articlesThe acting commissioner of the US Food and Drug Administration (FDA) has clarified that certain policies disseminated in medical journals by former FDA Commissioner Marty Makary are not official ag…raps · 15d ago↗ source
- BIO San Diego 2026 Executive InterviewsEvery year, the BIO International Convention brings together more than 20,000 leaders from across the global life sciences ecosystem.